Targeting the cell cycle inhibitor p57Kip2 promotes adult human β cell replication

Journal of Clinical Investigation

Volumn 124, Issue 2, 2014, Pages 670-674

  Avrahami, Dana ^a,b   Li, Changhong ^c   Yu, Ming ^a   Jiao, Yang ^a   Zhang, Jia ^a   Naji, Ali ^a   Ziaie, Seyed ^a   Glaser, Benjamin ^b   Kaestner, Klaus H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CALCIUM; CELL CYCLE; CELL SEPARATION; CELL TRANSPLANTATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE SILENCING; GLUCOSE; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; HYPERINSULINISM; INSULIN-SECRETING CELLS; LENTIVIRUS; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; RNA, SMALL INTERFERING; TRANS-ACTIVATORS;

EID: 84893870589     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69519     Document Type: Article

References (20)

1. Aynsley-Green A. Nesidioblastosis of the pancreas in infancy. Dev Med Child Neurol. 1981;23(3):372-379.
2. Thomas PM, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 1995; 268(5209):426-429.
3. Nestorowicz A, et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes. 1997;46(11):1743-1748.
4. Goossens A, et al. Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol. 1989;13(9):766-775.
5. Rahier J, Falt K, Muntefering H, Becker K, Gepts W, Falkmer S. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia. 1984;26(4):282-289.
6. Verkarre V, et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest. 1998;102(7):1286-1291.
7. Ryan F, et al. Hyperinsulinism: molecular aetiology of focal disease. Arch Dis Child. 1998;79(5):445-447.
8. Matsuoka S, et al. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci U S A. 1996;93(7):3026-3030.
9. Kassem SA, et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy. Diabetes. 2001;50(12):2763-2769.
10. Matsuoka S, et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995; 9(6):650-662.
11. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49(8):1325-1333.
12. Singer O, Verma IM. Applications of lentiviral vectors for shRNA delivery and transgenesis. Curr Gene Ther. 2008;8(6):483-488.
13. Levitt HE, et al. Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice. Diabetologia. 2011;54(3):572-582.
14. Meier JJ, et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes. 2008; 57(6):1584-1594.
15. Rieck S, et al. Overexpression of hepatocyte nuclear factor-4alpha initiates cell cycle entry, but is not sufficient to promote beta-cell expansion in human islets. Mol Endocrinol. 2012;26(9):1590-1602.
16. Mah LJ, El-Osta A, Karagiannis TC. GammaH2AX as a molecular marker of aging and disease. Epigenetics. 2010;5(2):129-136.
17. Klochendler A, et al. A transgenic mouse marking live replicating cells reveals in vivo transcriptional program of proliferation. Dev Cell. 2012; 23(4):681-690.
18. Wollheim CB, Sharp GW. Regulation of insulin release by calcium. Physiol Rev. 1981;61(4):914-973.
19. Bramswig NC, et al. Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming. J Clin Invest. 2013;123(3):1275-1284.
20. Fiaschi-Taesch NM, et al. Induction of human beta-cell proliferation and engraftment using a single G1/S regulatory molecule, cdk6. Diabetes. 2010; 59(8):1926-1936. Kidney Diseases Kidney Diseases Kidney Diseases